References

  1. World Health Organization. Tuberculosis IGRA TB Test, Policy Statement. The use of TB Interferon-Gamma Release Assays (IGRAs) in Low- and Middle-income Countries. 201. PubMed | Google Scholar

  2. Kabra, [edited by] Vimlesh Seth, SK. Essentials of tuberculosis in children. New Delhi: Jaypee Bros. 2006; (3rd ed): Medical Publishers. PubMed | Google Scholar

  3. World Health Organization. Group of risk. WHO global tuberculosis report. 2012. PubMed | Google Scholar

  4. World Health Organization. Epidemiology. Global tuberculosis control: epidemiology, strategy, financing mates of TB burden. 2009; 6-33. PubMed | Google Scholar

  5. Skolnik Richard. Global health 101. Jones & Bartlett Learning. 2011; (2nd ed): Burlington, MA. PubMed | Google Scholar

  6. Birn Anne-Emanuelle, Pillay Y, Holtz Timothy H. Textbook of International Health: Global Health in a Dynamic World. 2009; 3rd edition: Oxford University Press. Google Scholar

  7. Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology. Saunders Elsevier. 2007; 8th ed. PubMed | Google Scholar

  8. Brennan Patrick J, Nikaido Hiroshi. The envelope of mycobacteria. Annu Rev Biochem. 1995; 64: 29-63. PubMed | Google Scholar

  9. Lawn Stephen D, Zumla AI. Tuberculosis. Lancet. 2011; 378 (9785): 57-72. PubMed | Google Scholar

  10. Menzies Dick, Al Jahdali H, Al Otaibi Badriah. Recent developments in treatment of latent tuberculosis infection. The Indian journal of medical research. 2011; 133 (3): 257-66. PubMed | Google Scholar

  11. Tsaku Isaac Mary, Akyala Ishaku, Amuta EU. A retrospective study on the mortality rate of Human Immunodeficiency Virus (Hiv) And pulmonary tuberculosis (PTB) co-infected individuals in Nasarawa State, Nigeria. Journal of Biology, Agriculture and Healthcare. 2011; 3(7): 218-224. PubMed | Google Scholar

  12. Iliyasu Zubairu, Babashani M. Prevalence and Predictors of TB coinfection Among HIV seropositive patients attending Aminu Kano Teaching Hospital, Northern Nigeria. J Epidemiol. 2009; 19(2):81-87. PubMed | Google Scholar

  13. Maori Lynn . Prevalence of Tuberculosis among HIV/AIDS Patients Attending Zambuk General Hospital. NY Sci J. 2012; 5(5):33-36. PubMed | Google Scholar

  14. Nwobu G Obiora, Okodua MA, Tatfeng Y Mirabeau. Comparative study of HIV Associated Pulmonary Tuberculosis in Chest Clinics from Two Regions of Edo State, Nigeria. Online J Hlth Allied Scs. 2004; 3: 4. PubMed | Google Scholar

  15. Onubogu CC, Kunle-Ope CN, Onyejepu N, Nwokoye NN, Raheem TY, Igbasi UT, Tochukwu NE, Omoleye RM, Ejezie CO, Musa AZ, Odunukwe NN, Onwujekwe DI and Idigbe EO. Prevalence of Tuberculosis and Human Immune deficiency Virus (TB/HIV) Co-infection amongst patients with broncho pulmonary disorders in Lagos. African Journal of Microbiology Research. 2010; 4(18): 1904-1908. PubMed | Google Scholar

  16. Pym S Alexander, Domenech P, Honore N, Song J, Deretic V, Cole T Stewart. Regulation of catalase- peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol Microbiol. 2001; 40:879-889. PubMed | Google Scholar

  17. O'Brien Richard J. Drug- resistant tuberculosis: etiology, management and prevention. Semin Respir Infect. 1994; 9 (2): 104-112. PubMed | Google Scholar

  18. Volmink Jimmy, Garner P. Directly observed therapy for treating tuberculosis, In Volmink Jimmy. Cochrane Database Syst Rev. 2007; (4): CD003343. PubMed | Google Scholar

&